![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]()
Melbourne, Australia (UPI) Jul 20, 2004 Australian researchers have developed a therapeutic cancer vaccine that has appeared to delay cancer recurrence. Researchers at the Ludwig Institute for Cancer Research and the Australian biotechnology company CSL Limited said the vaccine, called NY-ESO-1/ISCOMATRIXTM, induced a comprehensive immune response in patients and Of every 19 patients, most with melanoma, treated with three monthly doses of the vaccine following surgical removal of the tumor, 14 remained cancer free over the two years their progress was followed. The vaccine, which combines a cancer-specific protein with an immune stimulant, appeared to delay the recurrence of cancer, suggesting that some form of protection is being conferred by the vaccine, the researchers said. Despite the encouraging clinical results, the researchers cautioned that the study was done retrospectively and therefore should be considered less exact than if it been done in a planned, prospective fashion. Phase II of the study will begin clinical trials in 2005 at cancer centers in Australia, New Zealand and the United Kingdom. All rights reserved. Copyright 2004 by United Press International. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by United Press International. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of by United Press International. Community Email This Article Comment On This Article Related Links SpaceDaily Search SpaceDaily Subscribe To SpaceDaily Express Space Medicine Technology and Systems
![]() ![]() A new computational tool developed at the Department of Energy's Pacific Northwest National Laboratory is speeding up our understanding of the machinery of life - bringing us one step closer to curing diseases, finding safer ways to clean the environment and protecting the country against biological threats. |
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |